President Donald Trump posted on X Thursday that he will nominate retired Rear Admiral Erica Schwartz to lead the Centers for Disease Control and Prevention. Schwartz, a Navy officer and former deputy surgeon general, has a record of supporting vaccines and public‑health prevention. Senate confirmation is now required, and she would become the agency’s fourth leader in just over a year in Washington.

Schwartz’s résumé includes degrees in biomedical engineering, medicine, public health and law, and she oversaw the federal COVID‑19 testing program during the pandemic. Her appointment signals a shift away from Health Secretary Robert F. Kennedy Jr.’s vaccine‑skeptical agenda, which had prompted a court‑ordered rollback of altered childhood‑vaccine schedules. The new leadership team also adds a Walmart executive as deputy director and a Texas health commissioner as chief medical officer. The White House also named former FDA acting commissioner Sara Brenner as senior counselor to Kennedy, completing a slate aimed at restoring scientific credibility.

With morale low after layoffs, an Atlanta shooting and plummeting public trust, Schwartz will inherit a workforce that has been through rapid turnover. Investors watch the CDC because its guidance influences pharmaceutical sales, hospital revenues and biotech research funding. Her confirmed appointment should steady market expectations around vaccine policy and reduce regulatory uncertainty for health‑care companies.